- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01922310
Communication Regarding Organ and Tissue Donation in Intensive Care (COMFORT)
October 3, 2017 updated by: NSW Organ and Tissue Donation Service
Communication With Families Regarding Organ and Tissue Donation After Death in Intensive Care Study
The overarching aim of this study is to examine the process of organ donation decision-making and to determine whether changes in requesting practices change rates of consent for donation, and other family-based outcomes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
417
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New South Wales
-
New Lambton Heights, New South Wales, Australia, 2305
- John Hunter Hospital
-
Sydney, New South Wales, Australia, 2145
- The Children's Hospital at Westmead
-
Sydney, New South Wales, Australia, 2065
- Royal North Shore Hospital
-
Sydney, New South Wales, Australia, 2010
- St Vincent's Hospital
-
Sydney, New South Wales, Australia, 2031
- Prince of Wales Hospital
-
Sydney, New South Wales, Australia, 2217
- St George Hospital
-
Sydney, New South Wales, Australia, 1871
- Liverpool Hospital
-
Sydney, New South Wales, Australia, 2052
- Royal Prince Alfred Hospital
-
Sydney, New South Wales, Australia, 2217
- NSW Organ and Tissue Donation Service
-
Tweed Heads, New South Wales, Australia, 2485
- The Tweed Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Donation events identified by a patient who is a potential organ and tissue donor in a participating ICU or under the care of ICU health professionals.
- For the primary endpoint only, patients must not have registered their donation wishes.
Exclusion Criteria:
- A patient who is not medically suitable for organ or tissue donation.
- A patient who does not have next of kin available to participate in donation conversations.
- A patient in the ICU who is able to provide first person consent for deceased donation, for example a patient with spinal injuries.
- A patient who is suitable to donate only tissue after death.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Communication intervention
This study uses a single arm design with current 'controls' to explore an intervention, the procedure for providing information and requesting consent for donation, that uses new agreed best practice procedures led by specially trained intensive care health professionals.
The study intervention is a staff education and training module intended to provide a framework and preparation for select critical care staff to conduct organ donation discussions in line with best practice.
|
The intervention is a modification of current standard practice procedures for requesting consent for donation. The intervention period commences when the possibility of organ donation is first raised with the family, and includes the time for families to make a decision. This time may last up to 72 hours. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of families providing consent for deceased organ donation.
Time Frame: Up to 72 hours subsequent to raising deceased donation with next of kin.
|
Final decision of either written or verbal consent or decline to deceased organ donation provided at the hospital.
|
Up to 72 hours subsequent to raising deceased donation with next of kin.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of senior next of kin who report they regretted their final decision either to consent or to decline donation.
Time Frame: 90 days post enrollment.
|
This outcome will be assesed using a telephone follow-up call.
|
90 days post enrollment.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Health professionals' adherence rates to core elements of the intervention.
Time Frame: Up to 72 hours subsequent to next of kin making their final donation decision.
|
This will be measured by observation and self-report at the hospital.
|
Up to 72 hours subsequent to next of kin making their final donation decision.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Robert Herkes, NSW Organ and Tissue Donation Service
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Potter JE, Perry L, Elliott RM, Aneman A, Brieva JL, Cavazzoni E, Cheng AT, O'Leary MJ, Seppelt IM, Herkes RG; COMFORT study investigators. Communication with Families Regarding Organ and Tissue Donation after Death in Intensive Care (COMFORT): a multicentre before-and-after study. Crit Care Resusc. 2018 Dec;20(4):268-276.
- Potter JE, Herkes RG, Perry L, Elliott RM, Aneman A, Brieva JL, Cavazzoni E, Cheng AT, O'Leary MJ, Seppelt IM, Gebski V; COMFORT study investigators. COMmunication with Families regarding ORgan and Tissue donation after death in intensive care (COMFORT): protocol for an intervention study. BMC Health Serv Res. 2017 Jan 17;17(1):42. doi: 10.1186/s12913-016-1964-7.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2013
Primary Completion (Actual)
July 8, 2016
Study Completion (Actual)
December 21, 2016
Study Registration Dates
First Submitted
August 10, 2013
First Submitted That Met QC Criteria
August 12, 2013
First Posted (Estimate)
August 14, 2013
Study Record Updates
Last Update Posted (Actual)
October 5, 2017
Last Update Submitted That Met QC Criteria
October 3, 2017
Last Verified
October 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- DR-01-2012
- ACTRN12613000815763 (Registry Identifier: Australian New Zealand Clinical Trials Registry (ANZCTR))
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tissue and Organ Procurement
-
Rahmah Health FoundationRawalpindi Medical CollegeCompletedTissue and Organ ProcurementPakistan
-
Centre Hospitalier Universitaire de NīmesCompleted
-
University of HawaiiHealth Resources and Services Administration (HRSA)Completed
-
Case Western Reserve UniversityNational Institute on Minority Health and Health Disparities (NIMHD); Robert...CompletedHealth Behavior | Tissue and Organ ProcurementUnited States
-
Case Western Reserve UniversityTerminatedCommunication | Adolescent Behavior | Tissue and Organ ProcurementUnited States
-
Radboud University Medical CenterCompletedTissue and Organ ProcurementNetherlands
-
University of HawaiiNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedTissue and Organ Procurement | Alcohol AbstinenceUnited States
-
University Health Network, TorontoThe Physicians' Services Incorporated Foundation; Trillium Gift of Life Network...UnknownTissue and Organ Procurement
-
Swedish Intensive Care RegistryCompletedTerminal Illness | Decision Making | Tissue and Organ ProcurementSweden
-
Assistance Publique - Hôpitaux de ParisAgence de La Biomédecine; Fondation de FranceCompletedTissue and Organ Procurement | Death, Assisted | Life Support CareFrance
Clinical Trials on Communication intervention
-
Centers for Disease Control and PreventionUniversity of GeorgiaCompletedHIV Infections | Sexually Transmitted Diseases | PregnancyUnited States
-
Clinical Research Centre, MalaysiaMinistry of Health, Malaysia; National University of Malaysia; Institute for...TerminatedBreast Neoplasm FemaleMalaysia
-
Duke UniversityCompletedImproved Communication Between Clinician and PatientUnited States
-
Duke UniversityUniversity of MichiganCompletedCommunication Improvement Between Adolescent and ClinicianUnited States
-
Ohio State University Comprehensive Cancer CenterBreast Cancer Research FoundationCompletedHealthy | Obesity | PostmenopausalUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)Terminated
-
Hong Kong Metropolitan UniversityRecruiting
-
University of Colorado, DenverRecruitingHospice | Alzheimer's Disease and Related Dementias | Sexual and Gender MinoritiesUnited States
-
M.D. Anderson Cancer CenterNot yet recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Malignant Solid Neoplasm | Locally Advanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
Marmara UniversityCompletedAnxiety | Patient Participation | Patient Empowerment | Health Communication | Patient-Centered Care | Neoplasms (Cancer / Tumors)Turkey (Türkiye)